Feb 3, 2014
UPDATE 2-Pfizer breast cancer drug succeeds in mid-stage trial
Pfizer Inc's experimental breast cancer drug significantly delayed progression of symptoms in a mid-stage trial, meeting the study's primary goal and keeping Pfizer in the forefront of a race for a new standard of care for the disease.
Exercise Might Ease Joint Pain Caused by Breast Cancer Drugs
Exercise might help breast cancer survivors relieve the joint pain that is a side effect of their medications, researchers say.
The Motley Fool
3 New Breast Cancer Treatments Worth Watching
Here come the new challengers Novartis, Pfizer, and Eli Lilly are racing against each other to launch a new class of breast-cancer treatments known as CDK inhibitors.
Generic drugs play a central role in reining in health care spending
It was a huge relief to Carol Thompson in 2011 when her breast cancer drug Femara went off patent and became available in a generic version.